140 related articles for article (PubMed ID: 38606836)
1. Daptomycin and ceftaroline combination for the treatment of persistent methicillin-resistant
Alsowaida YS; Alsolami A; Almangour TA
J Chemother; 2024 Apr; ():1-6. PubMed ID: 38606836
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline.
Sakoulas G; Moise PA; Casapao AM; Nonejuie P; Olson J; Okumura CY; Rybak MJ; Kullar R; Dhand A; Rose WE; Goff DA; Bressler AM; Lee Y; Pogliano J; Johns S; Kaatz GW; Ebright JR; Nizet V
Clin Ther; 2014 Oct; 36(10):1317-33. PubMed ID: 25017183
[TBL] [Abstract][Full Text] [Related]
3.
Davis KP; McDermott LA; Snydman DR; Aldridge BB
Microbiol Spectr; 2024 Jun; ():e0097624. PubMed ID: 38916355
[TBL] [Abstract][Full Text] [Related]
4. A combination of ceftaroline and daptomycin has synergistic and bactericidal activity in vitro against daptomycin nonsusceptible methicillin-resistant Staphylococcus aureus (MRSA).
Shafiq I; Bulman ZP; Spitznogle SL; Osorio JE; Reilly IS; Lesse AJ; Parameswaran GI; Mergenhagen KA; Tsuji BT
Infect Dis (Lond); 2017 May; 49(5):410-416. PubMed ID: 28116950
[TBL] [Abstract][Full Text] [Related]
5. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
Claeys KC; Zasowski EJ; Casapao AM; Lagnf AM; Nagel JL; Nguyen CT; Hallesy JA; Compton MT; Kaye KS; Levine DP; Davis SL; Rybak MJ
Antimicrob Agents Chemother; 2016 Oct; 60(10):5841-8. PubMed ID: 27431221
[TBL] [Abstract][Full Text] [Related]
6. Comparing the Outcomes of Ceftaroline plus Vancomycin or Daptomycin Combination Therapy versus Vancomycin or Daptomycin Monotherapy in Adults with Methicillin-Resistant
Huang C; Chen I; Lin L
Antibiotics (Basel); 2022 Aug; 11(8):. PubMed ID: 36009973
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Daptomycin Plus Ceftaroline Versus Alternative Therapy for Persistent Methicillin-resistant Staphylococcus aureus (MRSA) Bacteraemia.
Patel D; Brown ML; Edwards S; Oster RA; Stripling J
Int J Antimicrob Agents; 2023 Mar; 61(3):106735. PubMed ID: 36690124
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the in vivo efficacy of ceftaroline fosamil, vancomycin and daptomycin in a murine model of methicillin-resistant Staphylococcus aureus bacteraemia.
García P; Moscoso M; Fernández MC; Fuentes-Valverde V; Pérez A; Bou G
Int J Antimicrob Agents; 2023 Jul; 62(1):106836. PubMed ID: 37150362
[TBL] [Abstract][Full Text] [Related]
9. Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
Zasowski EJ; Trinh TD; Claeys KC; Casapao AM; Sabagha N; Lagnf AM; Klinker KP; Davis SL; Rybak MJ
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895012
[TBL] [Abstract][Full Text] [Related]
10. Ceftaroline Plus Daptomycin for Refractory Methicillin- Resistant Staphylococcus aureus Bacteremia in a Child.
Hall AM; McTigue SM
J Pediatr Pharmacol Ther; 2018; 23(6):490-493. PubMed ID: 30697136
[TBL] [Abstract][Full Text] [Related]
11. Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.
Arshad S; Huang V; Hartman P; Perri MB; Moreno D; Zervos MJ
Int J Infect Dis; 2017 Apr; 57():27-31. PubMed ID: 28131729
[TBL] [Abstract][Full Text] [Related]
12. Using an Ordinal Approach to Compare Outcomes Between Vancomycin Versus Ceftaroline or Daptomycin in MRSA Bloodstream Infection.
Barlow A; Heil EL; Claeys KC
Infect Dis Ther; 2021 Mar; 10(1):605-612. PubMed ID: 33484408
[TBL] [Abstract][Full Text] [Related]
13. Early Initiation of Ceftaroline-Based Combination Therapy for Methicillin-resistant Staphylococcus aureus Bacteremia.
Hicks AS; Dolan MA; Shah MD; Elwood SE; Platts-Mills JA; Madden GR; Elliott ZS; Eby JC
Res Sq; 2024 Mar; ():. PubMed ID: 38559201
[TBL] [Abstract][Full Text] [Related]
14. Combination ceftaroline and daptomycin salvage therapy for complicated methicillin-resistant Staphylococcus aureus bacteraemia compared with standard of care.
Johnson TM; Molina KC; Miller MA; Kiser TH; Huang M; Mueller SW
Int J Antimicrob Agents; 2021 Apr; 57(4):106310. PubMed ID: 33609718
[TBL] [Abstract][Full Text] [Related]
15. Ceftaroline and Daptomycin Combination Antibiotic Therapy for a Methicillin-Resistant
Heger ML; Al-Sayyad B
J Pediatr Pharmacol Ther; 2022; 27(8):754-759. PubMed ID: 36989005
[No Abstract] [Full Text] [Related]
16. Successful Treatment of Methicillin-Resistant
Patatanian E; Chandler C
Hosp Pharm; 2016 Jan; 51(1):68-70. PubMed ID: 38745720
[TBL] [Abstract][Full Text] [Related]
17. Bacteremia due to Methicillin-Resistant Staphylococcus aureus: New Therapeutic Approaches.
Holubar M; Meng L; Deresinski S
Infect Dis Clin North Am; 2016 Jun; 30(2):491-507. PubMed ID: 27208769
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin or Daptomycin Plus a β-Lactam Versus Vancomycin or Daptomycin Alone for Methicillin-Resistant
Yi YH; Wang JL; Yin WJ; Xu WH
Microb Drug Resist; 2021 Aug; 27(8):1044-1056. PubMed ID: 33728980
[No Abstract] [Full Text] [Related]
19. Comparing the Outcomes of Ceftaroline Plus Vancomycin or Daptomycin Combination Therapy Versus Monotherapy in Adults with Complicated and Prolonged Methicillin-Resistant Staphylococcus Aureus Bacteremia Initially Treated with Supplemental Ceftaroline.
Ahmad O; Crawford TN; Myint T
Infect Dis Ther; 2020 Mar; 9(1):77-87. PubMed ID: 31776844
[TBL] [Abstract][Full Text] [Related]
20. Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.
Geriak M; Haddad F; Rizvi K; Rose W; Kullar R; LaPlante K; Yu M; Vasina L; Ouellette K; Zervos M; Nizet V; Sakoulas G
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]